The global angiography devices market is expected to reach a valuation of US$ 12,717.9 million in 2023. The expanding application and technology innovation scope is projected to be the market's primary growth drivers. The overall sales of angiography devices are projected to record a robust CAGR of 6.2% between 2023 and 2033, totaling around US$ 23,309.3 million by the end of 2033.
The conspicuous growth of the global healthcare industry's demand for accurate diagnosis and procedural equipment has positively influenced the consumption of angiography devices. Given the massive prevalence of cardiovascular diseases, the clamor for angiography devices is projected to rise further.
Medical and surgical technology advancements are assumed to contribute to the higher production of angiography devices. The precision of angiography devices may continue to influence their deployment by the world's leading medical organizations. Angiography devices, used to detect heart failures, may remain a significant trend in the global medical industry. As a result of this trend, the usage of angiography devices may grow exponentially, benefiting end-user well-being as well.
The high incidence of diseases such as cancer and CVDs, enhancing product approvals for sophisticated angiography techniques in the market, a substantial percentage of active research activities, burgeoning government and public-private investments, a growing amount of programs and initiatives, and high adoption of angiography devices due to the large angiography procedures performed globally all contribute to the market's development.
| Report Attributes or Data Points | Details |
|---|---|
| Global Angiography Devices Market Valuation in 2022 | US$ 12,116.7 million |
| Estimated Global Market Share in 2023 | US$ 12,717.9 million |
| Forecasted Global Market Size by 2033 | US$ 23,309.3 million |
| Projected Global Market Growth Rate from 2023 to 2033 | 6.2% CAGR |
| Historical Market Growth Rate from 2018 to 2022 | 4.1% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to Future Market Insights, global demand for angiography devices is assumed to rise at a CAGR of 6.2% between 2023 and 2033, which compares favorably to a 4.1% CAGR from 2018 to 2022. The extensive use of angiography devices in cardiometabolic therapeutic interventions may be a key factor driving the growth of the global angiography devices market.
Furthermore, the emergence of new and upgraded products is expected to supplement the market for angiography devices. The devices, anticipated to be available in the vast bulk of hospitals, are also used to mitigate the incidence rate of cardiac diseases. As a result, demand for angiography devices is expected to continue for decades, boosting the market growth during the forecast period.
Investments in the healthcare sector are escalating. The angiography devices market is also witnessing a surge in investment from government and non-government organizations. The increment of healthcare infrastructure in several countries may provide lucrative business potential growth.
Furthermore, beneficial federal regulations for certification in various developed regions are expected to fuel global market expansion. A reversal in preference toward minimally invasive procedures is also a racing requirement for angiography systems. Furthermore, rapid advancements in angiography equipment are improving diagnostic methods and are estimated to generate market growth.
If the device is damaged due to unforeseeable factors, the manufacturers do not reimburse or exchange the costs. Local medical facilities restrict the use of fragile angiography devices, lowering the diagnosis of cardiovascular diseases. The changing medical regulations necessitate the regular modernization of angiography devices, which confines the demand for existing or primitive devices and equipment. The high cost of angiography devices has resulted in the emergence of relatively cheap, inaccurate, and mendacious angiography equipment, which diversifies demand in the global angiography devices market.
Principal Consultant
North America remained dominant in the global market in terms of revenue, accumulating a 37.2% share in 2022. Because of the higher prevalence of cardiac diseases, the United States and Canada are projected to augment angiography devices. According to the American Heart Association (AHA), 45 percent of the United States population may experience at least one heart-related problem. It also predicts that the costs of cardiovascular diseases may soar by 100% between 2016 and 2035. Furthermore, a sophisticated healthcare system allows for the wider utilization of new and advanced angiography devices.
The FDA approved it in March 2020, permitting it to be launched in the United States market. Furthermore, at the Radiological Society of North America (RSNA) 2020 virtual meeting, GE Healthcare debuted the Allia IGS 7 angiography system. The system employs artificial intelligence to strengthen the use of rotational angiography. North America is expected to hold a global market share of 33% in 2022.
Besides that, according to a research paper titled 'Cardiac Catheterization Risks and Complications,' in 2021, cardiac catheterization surgical operations on an annual basis in the United States were 1,000,000. Thus, there is a greater necessity for coronary angiography devices in the United States, further expanding the overall market in North America.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| North America | 37.2% |
| Europe | 28.1% |
Asia Pacific is anticipated to grow substantially due to a spike in the volume of CVD cases, as well as greater investment in the region's healthcare system, which may result in the accessibility of necessary medical facilities. As per FMI, an average CAGR of 6% is anticipated for the Asia Pacific market.
In comparison to cardiac catheterization, Coronary Angiography has very elevated accuracy in detecting patients with coronary heart disease. As a result, there is an increase in demand for Coronary Angiography Devices in this region.
The Japanese administration's favorable reimbursement policies to promote technological breakthroughs are aiding and abetting the region's growth. In countries such as South Korea, Brazil, and India, the regulatory environment is less stringent, creating an intriguing opportunity for global companies to establish a presence in these markets. China is consolidating to improve the quality of this equipment. Rising imports from leading market players such as GE Healthcare, Siemens Healthcare, and Koninklijke Philips N.V. are propelling the China angiography market forward.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| United States | 34.1% |
| Germany | 8.2% |
| Japan | 8.3% |
The Europe market is anticipated to register a CAGR of around 5.2% between 2022 and 2032. Burgeoning minimally invasive surgical interventions, increased emphasis on research and development capabilities in medical devices and on the adoption of advanced healthcare technologies, an increase in robotic-assisted surgical procedures, and rising expenditure on healthcare infrastructure development are the key factors driving the growth of the market in this region.
Furthermore, in Europe, the unhealthy lifestyle of the working segment of society may cause a spike in heart ailments, inciting the growth of the angiography devices market. Europe held a global market share of 28.1% in 2022.
| Regional Markets | CAGR (2023 to 2033) |
|---|---|
| United Kingdom | 5.9% |
| China | 8.3% |
| India | 7.7% |
| Australia | 5% |
Based on the device, MRA is anticipated to be the fastest-growing technology in the diagnosis of heart disease because of its minimal radiation exposure. MRA can acquire images in any anatomical plane with fantastic soft tissue contrast in 3D. The advent of 3.0T MR imaging has greatly improved the diagnosis of coronary artery disease. These factors are said to boost segment growth as well.
In 2019, the diagnostic application dominated the market. CTA and MRA advancements provide useful information not only in cardiology but also in neurology, such as cerebral aneurysms, acute stroke, brain arteriovenous malformation, dural arteriovenous fistula, suspected cerebral vasculitis, and occlusive diseases.
| Category | By Procedure |
|---|---|
| Top Segment | Coronary Angiography |
| Market Share in Percentage | 48.7% |
| Category | By End User |
|---|---|
| Top Segment | Hospitals and Surgical Centers |
| Market Share in Percentage | 61.1% |
Historically, based on the end-users segment, the hospitals, and surgical centers segment occupied the dominant share of the global market. This segment's growth can be attributed to the wide range of patients diagnosed and treated in hospitals, hospitals' high purchasing capacity for advanced technologies, the enormous percentage of diagnostic and therapeutic angiographic procedures, and growing recognition of the effects of timely disease diagnosis.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interest of potential buyers and create a larger customer base. For instance,
Inorbvict Healthcare India Private Limited is a private company founded on August 21, 2014. It is headquartered in Pune, Maharashtra, India. They recently introduced a low-cost Angiography System to the market.
Some leading angiography device manufacturers include Abbott Vascular (Abbott Laboratories), Toshiba Medical Systems Corporation, Royal Philips Electronics, GE Healthcare, Medtronic, Inc., Cordis Corporation, Shimadzu Corporation, and Siemens Healthcare.
These key angiography device providers are adopting strategies, such as new product launches and approvals, partnerships, collaborations, acquisitions, mergers, etc., to increase their sales and gain a competitive edge in the global angiography devices market. For instance,
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.2% from 2023 to 2033 |
| Market Value in 2023 | US$ 12,717.9 million |
| Market Value in 2033 | US$ 23,309.3 million |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The growth potential of the angiography devices market is 6.2% CAGR through 2033.
The market is expected to be valued at US$ 23,309.3 million by 2033.
North America enjoys monopoly in the angiography devices market.
India and China dominate the Asian market.
Abbott Vascular (Abbott Laboratories), Toshiba Medical Systems Corporation, and Royal Philips Electronics are key market players.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Device 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Device, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Device, 2023 to 2033 5.3.1. Magnetic Resonance Angiography (MRA) 5.3.2. Computed Tomography Angiography (CTA) 5.3.3. Conventional 5.3.4. Digital Subtraction Angiography (DSA) 5.3.5. Catheter 5.3.6. Coronary 5.3.7. Other 5.4. Y-o-Y Growth Trend Analysis By Device, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Device, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Procedure, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Procedure, 2023 to 2033 6.3.1. Coronary Angiography 6.3.2. Pulmonary Angiography 6.3.3. Cerebral Angiography 6.3.4. Extremity Angiography 6.3.5. Renal Angiography 6.4. Y-o-Y Growth Trend Analysis By Procedure, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Procedure, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033 7.3.1. Hospitals and Surgical Centres 7.3.2. Diagnostics Centres 7.3.3. Academic and Research Institutes 7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033 8.3.1. Coronary Artery Disease (CAD) 8.3.2. Congenital Heart Disease 8.3.3. Congestive Heart Failure 8.3.4. Kidney Disorders 8.3.5. Other Indications 8.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Device 10.2.3. By Procedure 10.2.4. By End User 10.2.5. By Indication 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Device 10.3.3. By Procedure 10.3.4. By End User 10.3.5. By Indication 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Device 11.2.3. By Procedure 11.2.4. By End User 11.2.5. By Indication 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Device 11.3.3. By Procedure 11.3.4. By End User 11.3.5. By Indication 11.4. Key Takeaways 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. UK 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Device 12.2.3. By Procedure 12.2.4. By End User 12.2.5. By Indication 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Device 12.3.3. By Procedure 12.3.4. By End User 12.3.5. By Indication 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Device 13.2.3. By Procedure 13.2.4. By End User 13.2.5. By Indication 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Device 13.3.3. By Procedure 13.3.4. By End User 13.3.5. By Indication 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Device 14.2.3. By Procedure 14.2.4. By End User 14.2.5. By Indication 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Device 14.3.3. By Procedure 14.3.4. By End User 14.3.5. By Indication 14.4. Key Takeaways 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Device 15.2.3. By Procedure 15.2.4. By End User 15.2.5. By Indication 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Device 15.3.3. By Procedure 15.3.4. By End User 15.3.5. By Indication 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Device 16.2.3. By Procedure 16.2.4. By End User 16.2.5. By Indication 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Device 16.3.3. By Procedure 16.3.4. By End User 16.3.5. By Indication 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Device 17.1.2.2. By Procedure 17.1.2.3. By End User 17.1.2.4. By Indication 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Device 17.2.2.2. By Procedure 17.2.2.3. By End User 17.2.2.4. By Indication 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Device 17.3.2.2. By Procedure 17.3.2.3. By End User 17.3.2.4. By Indication 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Device 17.4.2.2. By Procedure 17.4.2.3. By End User 17.4.2.4. By Indication 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Device 17.5.2.2. By Procedure 17.5.2.3. By End User 17.5.2.4. By Indication 17.6. UK 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Device 17.6.2.2. By Procedure 17.6.2.3. By End User 17.6.2.4. By Indication 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Device 17.7.2.2. By Procedure 17.7.2.3. By End User 17.7.2.4. By Indication 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Device 17.8.2.2. By Procedure 17.8.2.3. By End User 17.8.2.4. By Indication 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Device 17.9.2.2. By Procedure 17.9.2.3. By End User 17.9.2.4. By Indication 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Device 17.10.2.2. By Procedure 17.10.2.3. By End User 17.10.2.4. By Indication 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Device 17.11.2.2. By Procedure 17.11.2.3. By End User 17.11.2.4. By Indication 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Device 17.12.2.2. By Procedure 17.12.2.3. By End User 17.12.2.4. By Indication 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Device 17.13.2.2. By Procedure 17.13.2.3. By End User 17.13.2.4. By Indication 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Device 17.14.2.2. By Procedure 17.14.2.3. By End User 17.14.2.4. By Indication 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Device 17.15.2.2. By Procedure 17.15.2.3. By End User 17.15.2.4. By Indication 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Device 17.16.2.2. By Procedure 17.16.2.3. By End User 17.16.2.4. By Indication 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Device 17.17.2.2. By Procedure 17.17.2.3. By End User 17.17.2.4. By Indication 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Device 17.18.2.2. By Procedure 17.18.2.3. By End User 17.18.2.4. By Indication 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Device 17.19.2.2. By Procedure 17.19.2.3. By End User 17.19.2.4. By Indication 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Device 17.20.2.2. By Procedure 17.20.2.3. By End User 17.20.2.4. By Indication 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Device 17.21.2.2. By Procedure 17.21.2.3. By End User 17.21.2.4. By Indication 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2022 17.22.2.1. By Device 17.22.2.2. By Procedure 17.22.2.3. By End User 17.22.2.4. By Indication 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2022 17.23.2.1. By Device 17.23.2.2. By Procedure 17.23.2.3. By End User 17.23.2.4. By Indication 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Device 18.3.3. By Procedure 18.3.4. By End User 18.3.5. By Indication 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Abbott Vascular (Abbott Laboratories) 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.1.5.2. Product Strategy 19.1.1.5.3. Channel Strategy 19.1.2. Toshiba Medical Systems Corporation 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.2.5.2. Product Strategy 19.1.2.5.3. Channel Strategy 19.1.3. Royal Philips Electronics 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.3.5.2. Product Strategy 19.1.3.5.3. Channel Strategy 19.1.4. GE Healthcare 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.4.5.2. Product Strategy 19.1.4.5.3. Channel Strategy 19.1.5. Medtronic 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.5.5.2. Product Strategy 19.1.5.5.3. Channel Strategy 19.1.6. Cordis Corporation 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.6.5.2. Product Strategy 19.1.6.5.3. Channel Strategy 19.1.7. Shimadzu Corporation 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.7.5.2. Product Strategy 19.1.7.5.3. Channel Strategy 19.1.8. Siemens Healthcare. 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.8.5.2. Product Strategy 19.1.8.5.3. Channel Strategy 19.1.9. Canon Medical Systems 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.9.5.2. Product Strategy 19.1.9.5.3. Channel Strategy 19.1.10. St. Jude Medical Inc. 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 19.1.10.5.2. Product Strategy 19.1.10.5.3. Channel Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Healthcare
October 2020
REP-GB-12575
June 2023
220 pages
Explore Healthcare Insights
View Reports
Angiography Devices Market
